Apogee Therapeutics CEO Michael Henderson sells $2.67m in stock

Apogee Therapeutics CEO Michael Henderson sells $2.67m in stock investment News

All News
Apogee Therapeutics CEO Michael Henderson sells $2.67m in stock


Apogee Therapeutics CEO Michael Henderson sells $2.67m in stock

investment News

Continue Reading

Related market coverage